GT
AVNS

Glenmede Trust’s Avanos Medical AVNS Stock Holding History

Glenmede Trust’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-648
Closed -$21K – 1289
2020
Q3 		$21K Sell
648
-486
-43% -$15.5K ﹤0.01% 1593
2020
Q2 		$31K Sell
1,134
-721
-39% -$20.9K ﹤0.01% 1435
2020
Q1 		$61K Hold
1,855
– – ﹤0.01% 1597
2019
Q4 		$61K Sell
1,855
-72
-4% -$2.61K ﹤0.01% 1597
2019
Q3 		$71 Sell
1,927
-7,632
-80% -$291K ﹤0.01% 1520
2019
Q2 		$415 Buy
9,559
+851
+10% +$36.4K ﹤0.01% 951
2019
Q1 		$370 Buy
8,708
+4,032
+86% +$181K ﹤0.01% 973
2018
Q4 		$208 Sell
4,676
-2,899
-38% -$152K ﹤0.01% 1101
2018
Q3 		$518K Buy
7,575
+2,519
+50% +$162K ﹤0.01% 882
2018
Q2 		$289K Buy
5,056
+2,241
+80% +$118K ﹤0.01% 963
2018
Q1 		$128K Hold
2,815
– – ﹤0.01% 1314
2017
Q4 		$128K Sell
2,815
-9
-0.3% -$414 ﹤0.01% 1314
2017
Q3 		$126K Buy
2,824
+42
+2% +$1.79K ﹤0.01% 1357
2017
Q2 		$105K Hold
2,782
– – ﹤0.01% 1373
2017
Q1 		$105K Sell
2,782
-14
-0.5% -$546 ﹤0.01% 1373
2016
Q4 		$102K Buy
2,796
+1
+0% +$36 ﹤0.01% 1396
2016
Q3 		$95K Sell
2,795
-148
-5% -$5.18K ﹤0.01% 1413
2016
Q2 		$94K Sell
2,943
-412
-12% -$12.6K ﹤0.01% 1374
2016
Q1 		$95K Sell
3,355
-724
-18% -$19.3K ﹤0.01% 1343
2015
Q4 		$135K Sell
4,079
-956
-19% -$29.7K ﹤0.01% 1276
2015
Q3 		$142K Sell
5,035
-1,971
-28% -$68.8K ﹤0.01% 1279
2015
Q2 		$283K Sell
7,006
-615
-8% -$27.6K ﹤0.01% 1124
2015
Q1 		$374K Sell
7,621
-5,983
-44% -$277K ﹤0.01% 1077
2014
Q4 		$616K Buy
+13,604
New +$534K ﹤0.01% 845

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Trust's AVNS Position: Q4 2020 in Review

Glenmede Trust sold out of Avanos Medical (AVNS) in Q4 2020, closing a stake of 648 shares — an estimated $21K sold.

Glenmede Trust first reported a position in AVNS in Q4 2014 and held it in 24 quarters. The position peaked at $616K in Q4 2014. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • Glenmede Trust reported no remaining Avanos Medical position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 648 Avanos Medical shares in Q4 2020, an estimated $21K.
  • Glenmede Trust first reported a position in Avanos Medical in Q4 2014 and held it in 24 quarters.
  • Glenmede Trust's Avanos Medical position peaked at $616K in Q4 2014.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.